All EXEL SEC filings, by type → · Earnings date & implied move · Search inside filings

EXEL is not among the 142 companies we ingest every day, so it is not in the fundamentals screener or the size and group lists built from it. This page reads its SEC filings when the page is built. Ask us to add it: we keep a count per ticker and nothing about you.

Latest report (10-Q, filed 2026-10-29). Three months to 2026-10-02 against 2025-10-03: Revenue $658.7M, up 10.2% from $597.8M; Net income $218.1M, up 12.7% from $193.6M. Nine months to 2026-10-02 against 2025-10-03: Operating cash flow $839.5M, up 52.4% from $550.8M. Read it line by line, each linked to its source → · Every report →

/stocks/EXEL // the workspaceSource: SEC EDGAR · refreshed daily

EXEL

EXELIXIS, INC.
NASDAQ•Biological Products, (No Diagnostic Substances)
Last close · EOD$64.63▼ 1.82%
Fair Value?

Summary from SEC filings

EXELIXIS, INC. (EXEL) is a biological products, (no diagnostic substances) company. Piotroski F-Score 6/7. Next earnings projected around 2027-02-09 from EXEL's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.

Every filed figure on this page is free to read, dated and sourced; no column is held back for a paid plan. Each section with figures says what date they are true as of and where they come from.

MARKET CAP$15.77B
⊙
INFERENCE — derived by arithmetic
SourceLast close times filed shares outstanding
Fielddei:EntityCommonStockSharesOutstanding
As ofclose 2026-11-20; count as of 2026-10-19
Filing10-Q · 0000939767-26-000116 · filed 2026-10-29
How64.63 USD close on 2026-11-20 × 244,010,895 shares = 15.77 billion USD.
Open the filing on EDGAR →Open the XBRL payload →
P/E (FY)23.2
⊙
INFERENCE — derived by arithmetic
SourceLast close divided by diluted EPS
Fieldus-gaap:EarningsPerShareDiluted
As ofclose 2026-11-20; EPS FY ending 2026-01-02
How64.63 USD / 2.78 USD per share = 23.2.
Open the source document →
VOLUME2.2M
AVG VOL (30D)2.8M
EPS (FY)$2.78
OPEN$65.95
DAY RANGE$64.45 to $66.94
PREV CLOSE$65.83
52-WEEK RANGE$39.71 to $73.69
NEXT EARNINGS~Feb 9 est
Source: SEC EDGAR · fundamentalsEOD · as of 2026-11-20 close · delayed, not real-time, so no bid or askMarket cap = last close × filed share count. How the count is chosen
last close against its levels // closes, through 2026-11-20
  1. 52-week high close 72.75 2026-11-04
  2. 20-session average 68.60 simple, through 2026-11-20
  3. Prior close 65.83 2026-11-19
  4. Last close 64.63 2026-11-20
  5. 50-session average 63.20 simple, through 2026-11-20
  6. 200-session average 52.86 simple, through 2026-11-20
  7. 52-week low close 40.74 2026-03-03

Closes only, split-adjusted. An average needs that many sessions on file to print. These are measurements, not support, resistance or targets. Chart with studies

chart read // written by code from end-of-day closes
Recent range
Over the last 20 sessions the close ran from 64.63 on 2026-11-20 to 72.75 on 2026-11-04. The last close, 64.63 on 2026-11-20, sits 0% of the way up that range.
52-week range
The 52-week closing range runs from 40.74 on 2026-03-03 to 72.75 on 2026-11-04. The last close is 11.2% below the high close and 58.6% above the low close.
The window's move
The close changed +0.2% over the last 20 sessions. Of the 581 earlier 20-session windows on file since 2024-07-01, 1% were smaller in size, up or down. Over 63 sessions it changed +18.5%.
Averages
The last close is 2.3% above its 50-session average of 63.20 and 22.3% above its 200-session average of 52.86. The 50-session average sits 19.6% above the 200-session average.
Largest daily moves
The largest close-to-close moves of the last 63 sessions: -5.6% on 2026-11-05, +4.8% on 2026-10-30, +4.1% on 2026-09-01.
Daily range
Wilder's ATR over 14 sessions is 3.48% of the close. Its median over the last 252 sessions was 2.96%.
Volume
Volume on 2026-11-20 was 2,194,298 shares, 0.74 times the average of the 20 sessions before it. The last 20 sessions averaged 1.14 times the average of the last 252.
RSI (14)
Wilder's RSI over 14 sessions reads 43.4 on a scale of 0 to 100.
Resistance areas
The nearest resistance area our tool finds above the last close spans 73.41 to 73.97, 13.6% above. 3 sessions traded up into it and closed below it. It was last traded in on 2026-11-05. Measured on 136 tickers (2026-10-05), the nearest such area held, with no close above it for 5 sessions, 33.4% of the times it was reached within 20 sessions, against 33.3% for random bands of the same width: no measured edge.

Daily closes from 2024-07-01 through 2026-11-20, 602 sessions, split-adjusted. No direction, pattern, entry, target or overbought label: these are measurements. Filings dated on the move days are in EXEL’s filings; the chart with studies draws every figure.

Written by code from 602 end-of-day bars through 2026-11-20. Written by code from the data on file, not by a model. Information, not investment advice: it describes the security and recommends nothing to anyone.

AI writes the read above in plainer words, from those figures only. 1 generation (Pro), or free if someone already asked about the 2026-11-20 read.
why is it moving // cited AI read

What’s behind EXEL’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.

Share EXELFollow EXEL's filings, insiders, and whale activity — free, straight from the source.
price // EOD candlesdelayed, not real-time
close · daily bars, delayed · end-of-day bars (Databento)
Loading…

End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™

earnings center EXEL // expectation vs reality
last results 8-K filed · one 8-K per report, closes the session before and after · SEC 8-K Item 2.02 filings and end-of-day bars (Databento)
NEXT REPORT · confidence engineHIGH CONFIDENCE~ Feb 9 estUsually after the close, from past SEC filing timesProjected from year-over-year pattern · usually within ~3 days
  • 35 historical earnings 8-Ks (Item 2.02) on file
  • Reports on a ~91-day quarterly cadence (+/-7d)
  • Usually reports on a Tuesday (54% of quarters)
  • Results filed after the close in 8 of the last 8 reports, by EDGAR acceptance time
  • Last report filed 2026-10-29, accepted 4:09 PM ET

Projected from EXEL's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentEXEL files or announces.

The BreakdownEARNINGSdeterministic · from filings

EXEL's earnings reaction has been evenly split — 4 up, 4 down across its last 8 reports.

Typical move±6.4%
Average move±9.0%
Biggest earnings pop+20.7%
Biggest earnings drop-19.0%

Each figure is one earnings reaction — how much EXEL moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.

Large earnings reactions have been common.

The average is inflated by its most volatile prints (+20.7% and -19.0%).

A more typical earnings reaction has been approximately ±6.4%.

Realized close-to-close history only — no options-implied move, no analyst estimates.

PAST EARNINGS REACTIONS · 8 prints
ReportedMoveClose-to-closeReaction
2026-10-29+4.7%Bullish
2026-08-05-6.8%Bearish
2026-05-05+10.3%Bullish
2026-02-10-2.3%Bearish
2025-11-04+6.1%Bullish
2025-07-28-19.0%Bearish
2025-05-13+20.7%Bullish
2025-02-11-2.1%Bearish
next:DCF valuation →Options profit →Max pain & OI walls →Covered call yields →Support & resistance →Dividend history & yield →Earnings calendar →Congressional trades →

Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.

next 14 days // what each source returneda record of what was checked, not a forecast
SEC submissions read · calendar days, the next 14 · the company's own filings on SEC EDGAR, our 8-K date sweep and dates checked by hand

Nothing on file for EXEL from Nov 22, 2026 to Dec 5, 2026 in these sources: earnings date and filing deadline.

EventResultSource, and when
Earnings datenothing in the window. Nothing in the window. The next report is projected around Feb 9, 2027, after it.the company’s results 8-Ks on EDGAR (the projected window), our sweep of scheduling 8-Ks, and dates checked by hand on company pages; read 2026-11-22
Filing deadlinenothing in the window. Nothing in the window: the 10-K for the fiscal year ending between Dec 25, 2026 and Jan 8, 2027 (its periods end on a weekday, not a month end), due 60 days after it for a large accelerated filer, falls due between Feb 23, 2027 and Mar 9, 2027, after it. Newest periodic report on file: the 10-Q for the period ending Oct 2, 2026, filed Oct 29, 2026. filing list on EDGARSEC’s submissions file for the company: its filer status, fiscal year end and newest periodic report; read 2026-11-22
Ex-dividend datenot covered. Not checked. This attestation does not cover ex-dividend dates.none: we carry no declared ex-dividend dates, only the dividends companies report in their filings

This records what these sources returned when they were read. It is not a forecast: a company can announce an event at any time, and ex-dividend dates are not covered. Window 2026-11-22 to 2026-12-05, Eastern dates. Deadlines follow SEC Rules 13a-1 and 13a-13 and Form 20-F, moved past weekends and federal holidays by Rule 0-3.

fundamentals // from filings, not quotes
fiscal year ended · annual · SEC XBRL companyfacts
Revenue$2.32B+7.0% y/yFY
⊙
EVIDENCE — filed/published fact
SourceSEC XBRL companyfacts
FieldRevenueFromContractWithCustomerExcludingAssessedTax
As ofFY ending 2026-01-02
Filing10-K · 0000939767-26-000021 · filed 2026-02-10
Open the filing on EDGAR →Open the XBRL payload →
CiteEXELIXIS, INC. (EXEL), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 2,320,126,000 USD, fiscal year ended 2026-01-02. Form 10-K, accession 0000939767-26-000021, filed 2026-02-10. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000939767/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json
Net income$782.6M+50.1% y/yFY
⊙
EVIDENCE — filed/published fact
SourceSEC XBRL companyfacts
FieldNetIncomeLoss
As ofFY ending 2026-01-02
FilingDEF 14A · 0000939767-26-000046 · filed 2026-04-15
Open the filing on EDGAR →Open the XBRL payload →
CiteEXELIXIS, INC. (EXEL), us-gaap:NetIncomeLoss: 782,600,000 USD, fiscal year ended 2026-01-02. Form DEF 14A, accession 0000939767-26-000046, filed 2026-04-15. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000939767/us-gaap/NetIncomeLoss.json
EPS (diluted)$2.78+58.0% y/yFY
⊙
EVIDENCE — filed/published fact
SourceSEC XBRL companyfacts
FieldEarningsPerShareDiluted
As ofFY ending 2026-01-02
Filing10-K · 0000939767-26-000021 · filed 2026-02-10
Open the filing on EDGAR →Open the XBRL payload →
CiteEXELIXIS, INC. (EXEL), us-gaap:EarningsPerShareDiluted: 2.78 USD per share, fiscal year ended 2026-01-02. Form 10-K, accession 0000939767-26-000021, filed 2026-02-10. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000939767/us-gaap/EarningsPerShareDiluted.json

XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.

filings & insider activity // official0 FORM 4 / 90D
newest filing · the five newest 10-K, 10-Q and 8-K filings · SEC EDGAR submissions
10-Qquarterly reportThe quarterly report. Its statements are reviewed but not audited, and one quarter can mislead on its own.2026-10-29
8-Kresults announcedItem 2.02 says results were released, usually in an attached press release. It does not say results improved, and the figures are unaudited.press release →2026-10-29
8-Kother eventsItem 8.01 is for events the company chooses to report, with no required content. The label alone says nothing about the importance.2026-09-11
8-Kother eventsItem 8.01 is for events the company chooses to report, with no required content. The label alone says nothing about the importance.2026-08-31
10-Qquarterly reportThe quarterly report. Its statements are reviewed but not audited, and one quarter can mislead on its own.2026-08-05

Has EXEL been issuing shares? Offering history →

Volume against its own history: 38% of its last 252 sessions were lighter than the last one, the 2026-11-20 session. End-of-day bars (Databento). Volume detail

what is new on file for EXEL // four checks, each datedwhat was checked, not a judgement
congress feed generated · short interest settlement · four checks, each over 30 days back from its own source date · SEC EDGAR, Form 4, STOCK Act disclosures and FINRA short interest

2 of the 2 checks that ran found nothing new for EXEL. 2 could not run.

Filings
NOT CHECKED
Newest 10-K, 10-Q or 8-K on record: the 8-K (results announced) filed 2026-10-29. When this list was stored is not recorded for this company, so no "nothing since" claim is made.all filings →
Insider trades
NOT CHECKED
The Form 4 list for this company was read from source for this page build and that read time is not recorded, so no window claim is made. The insider panel below shows what was found.insider panel →
Congress trades
NOTHING NEW
No STOCK Act disclosure of a trade filed in the 30 days to 2026-11-20. None is on record in the feed. Members of Congress disclose a trade up to 45 days after it happens.
⊙
EVIDENCE — filed/published fact
SourceSTOCK Act disclosures (House Clerk, Senate eFD), via the Congress Trading Monitor
As of2026-11-20 (feed generated)
HowDates are filing dates as disclosed. Trades are reported up to 45 days after they happen.
Open the source document →
generated · congress panel →
Short interest
INSIDE RANGE
25,593,708 shares short at the 2026-10-30 settlement, inside the range of the 24 settlements in the 12 months before it (19,791,732 to 30,913,414, from 2025-10-31).
⊙
INFERENCE — derived by arithmetic
SourceFINRA consolidated short interest, biweekly archive
FieldcurrentShortPositionQuantity
As of2026-10-30 settlement
HowThe latest settlement against the lowest and highest of the 24 settlements in the 12 months before it. Arithmetic on FINRA's figures; not split-adjusted.
Open the source document →
settlement · short interest history →

Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.

lab scores // glass box, formulas shownTHE LAB →
fiscal year ended · against · Z-Score market value at close · annual, two filed fiscal years · SEC XBRL companyfacts
Piotroski F-Score6/7
⊙
INFERENCE — derived by arithmetic
SourcePiotroski F-Score: nine pass or fail tests on two filed fiscal years
As offiscal year ended 2026-01-02 against 2025-01-03
How6 of the 7 computable tests pass. 2 of 9 cannot be computed from the filings and are not counted as passes or fails. Arithmetic on filed XBRL facts.
Open the source document →
(2 of 9 checks not computable from filings)
  • ✓ Positive return on assets
  • ✓ Positive operating cash flow
  • ✓ Return on assets improved
  • ✓ Cash flow exceeds net income
  • not filed: Long-term leverage fell
  • ✗ Current ratio improved
  • ✓ No meaningful share issuance
  • not filed: Gross margin improved
  • ✓ Asset turnover improved
Altman Z-Score16.08
⊙
INFERENCE — derived by arithmetic
SourceAltman Z-Score, the original 1968 formula
As offiscal year ended 2026-01-02 against 2025-01-03; market value at the 2026-11-20 close
How1.2 × working capital / total assets + 1.4 × retained earnings / total assets + 3.3 × EBIT / total assets + 0.6 × market value / total liabilities + 1.0 × sales / total assets = 16.08. Balance sheet and income from the filings; market value is the stored market cap.
Open the source document →
SAFE ZONE (>2.99)

FY ending 2026-01-02 vs 2025-01-03. original 1968 formula; calibrated on manufacturers, read financials/REITs with care

Beneish M-Score— needs receivables, PP&E, SG&A, and depreciation facts for both years

fundamentals // annotated, interactivefrom XBRL filings
quarters ended · through · 12 quarters, as filed · SEC XBRL companyfacts
12 quarters of filed history · red = loss quarter · ★ = biggest revenue growth against the same quarter a year earlier
Mar '23Jun '23Sep '23Mar '24★Jun '24Sep '24Apr '25Jul '25Oct '25Apr '26Jul '26Oct '26$659M latest
From EXEL’s quarterly XBRL filings. Fastest revenue growth: the quarter ending Jun 2024 (+36% on a year earlier).
fair value band // 5 estimators, 20y of historya range, not a number
inputs from the fiscal year ended · price close · annual filings, one daily close · SEC XBRL companyfacts and end-of-day prices
FAIR VALUE BAND
$61.03 – $71.84
CURRENT PRICE
$64.63
PRICE IS ABOVE THE MIDPOINT BY
0%
$61.03band from 5 estimators$71.84
VALUATIONFair ValueFILING HEALTHSoundDISAGREEMENTLow17% spread · 5 estimators
  • No distress, manipulation or weak-fundamental flags
WHAT WENT INTO THE BAND
MEDIAN P/E
$71.84
the median P/E this stock has traded at, applied to current earnings (22.4x, 10 years)
MEDIAN P/S
$64.58
the median P/S this stock has traded at, applied to current revenue (6.8x, 18 years)
MEDIAN P/B
$40.77
the median P/B this stock has traded at, applied to current book value (4.6x, 14 years)
MEDIAN P/FCF
$61.03
the median P/FCF this stock has traded at, applied to current free cash flow (17.0x, 11 years)
TWO-STAGE DCF
$85.75
8% growth for 10y, 2.5% terminal, 9% discount
REFERENCE — Graham numberBenjamin Graham's ceiling for a cautious buyer: the highest share price his 1949 rule allows, at 15 times earnings and 1.5 times book value combined. A yardstick, not a forecast. $23.54. Shown beside the band, not inside it: it is a fixed 15×-earnings / 1.5×-book rule from 1949, not a multiple EXEL has ever traded at, and it double-counts book value against P/B.
?  What do these labels mean, and how is the band built?

The band is the interquartile range of every estimator that could run on EXEL’s filings: the median P/E, P/S, P/B and P/FCF this stock has actually traded at over 20 years of history applied to today’s fundamentals, a two-stage discounted-cash-flow estimate. With four or more estimators we take the interquartile range, so a single wild reading cannot define the band; with two or three we show the full spread, because trimming the tails off three points does not remove noise, it manufactures confidence. We publish a range rather than one number because the estimators genuinely disagree, and averaging that disagreement away would hide the most useful part.

Valuation labels describe only where the price sits against that band:

  • Significant Discount — price is more than 30% below the bottom of the band.
  • Discount — price is below the bottom of the band.
  • Fair Value — price sits inside the band, i.e. about where this company’s own fundamentals put it.
  • Premium — price is above the top of the band.
  • Significant Premium — price is more than 30% above the top of the band.

These labels are positional, not predictive. Premium means the current share price sits above the band computed from EXEL’s own filings and trading history. It does not mean the stock cannot keep rising, that a fall is expected, or that the market has it wrong. Equally, Discount means the price sits below that band — it does not imply the stock is cheap in any meaningful sense, that it is worth buying, or that the market has mispriced it. A company can trade above or below its own historical range for years, and often does, for reasons the range knows nothing about.

The labels describe where today’s price falls against a calculated band. Nothing more than that.

Measured disagreement is our answer to a locked “uncertainty rating”: it is simply how far the estimators spread as a share of the midpoint, tiered Low / Moderate / High / Extreme, with the raw spread shown beside it. A wide band earns a high tier because the answer then depends heavily on which yardstick you pick — that is a finding, not a defect.

Filing health is computed separately and never looks at price. It reads the Piotroski F-Score, the Altman Z-Score and the Beneish M-Score straight from the filings: Sound means none of them flagged, Mixed means one moderate flag, Weak means a distress or manipulation flag, or several softer ones. For banks and insurers it reads Not assessed: all three scores were built on non-financial companies and their authors excluded financials, so for a balance-sheet business they measure the shape of the business rather than its health. Keeping the two axes apart is deliberate — a cheap company with weak filings is a very different object from a cheap company with sound ones, and a single blended verdict would hide which you are looking at.

Why some estimators are skipped. A multiple can be arithmetically computable and still meaningless. GAAP depreciation crushes REIT earnings, so we do not price a REIT off P/E; revenue and free cash flow are not comparable measures for a bank or an insurer, so those are dropped too. We would rather show you the estimators we trust and name every one we withheld, with the reason, than quietly fold in a number we do not believe.

Every number above is arithmetic you can redo. The inputs are EXEL’s own SEC filings and our price history; the formulas are stated on this page. There is no proprietary black box, and there is nothing here you have to take on trust. How often the band rates a stock, and what we have not measured.

This is a computed description of a security against a published formula — not investment advice, not a recommendation, and not a price target. Labels describe EXEL against the band above; they say nothing about whether it suits your circumstances. Historical multiples are not a forecast, and a company can stay outside its own historical range for years. Educational information only.

price vs fair value // 18 fiscal yearsreconstructed, not asserted
through fiscal year · one point per fiscal year · SEC XBRL companyfacts and adjusted year-end closes
LATEST FY PRICE
$43.6
RECONSTRUCTED FAIR VALUE
$51.6
PREMIUM / DISCOUNT
-15%
$5.53$26.2$46.82010201320162017202120232026
—— price at FY end– – – reconstructed fair value

The fair-value line is EXEL’s own median P/E, P/S, P/B and P/FCF applied to each year’s fundamentals — the price its typical valuation would have implied. Where the solid line sits above the dashed one, the stock traded at a premium to its own history that year; below, a discount. This is a description of past valuation, computed from EXEL’s filings and price history — not a forecast and not investment advice. A stock can trade above or below its own median for years.

trailing returns // total return, dividends reinvestedpast, not a forecast
adjusted close · daily closes, dividends reinvested · Tiingo adjusted closes
1M
+7.3%
YTD
+33.2%
1Y
+44.3%
3Y
+172.5%
5Y
+181.7%

Total return including reinvested dividends, from EXEL’s adjusted closing prices. Past return is not a forecast and not investment advice.

capital allocation // where the cash wentreceipts, not a grade
fiscal year ended · annual · SEC XBRL companyfacts, cash flow statement
OPERATING CASH FLOW · FY FY ending 2026-01-02
$884.3M
FREE CASH FLOW
$875.8M
RETURNED TO SHAREHOLDERS
$947.5M · 108% of FCF
Reinvested in the business (capex)$8.4M · 1% of OCF
property, plant and equipment — money put back into operations.
Returned via share buybacks$947.5M · 107% of OCF
shares repurchased — returns cash and lifts per-share figures, but only creates value below intrinsic worth.

Shareholder returns exceeded free cash flow this period — the difference was funded from cash on hand, debt, or asset sales rather than the business itself. Common and sustainable for a period; worth watching if it persists.

Every figure is from EXEL’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.

smart money // insiders vs institutionstwo clocks, not one signal
insider trades through · Form 4 as filed, 13F quarterly · SEC Form 4 and Form 13F-HR
Insiders onlyInsider activity on EXEL, with no 13F position changes in the latest round.
INSIDERS · FORM 4
0 buy · 4 sell
Net −$3.4M. Open-market trades only — grants and option exercises are excluded, because they are compensation rather than a decision to buy. 3 of the sales were set up in advance under a Rule 10b5-1 plan.
INSTITUTIONS · 13F
0 adding · 0 trimming
1 tracked fund holds $747.2M.

From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.

filed figures against its sic group // one metric at a time, no compositemedian and percentile
fiscal year ended · oldest stored read · newest stored read · one annual report per company, newest on file · SEC XBRL annual reports as our valuation history stored them; SIC descriptions from EDGAR

Group: Biological Products, (No Diagnostic Substances), the SEC industry code EXEL files under. 4 companies in our stored table file under it.

MetricEXELGroup median25th to 75th percentileWhere EXEL sits
Net marginnet income divided by revenue, same fiscal yearWithheld: 4 companies in this SIC group have the figure on file, and a group prints from 6.
Free cash flow marginoperating cash flow less capital expenditure, divided by revenue, same fiscal yearWithheld: 4 companies in this SIC group have the figure on file, and a group prints from 6.
Return on equitynet income divided by stockholders’ equity at the fiscal year endWithheld: 4 companies in this SIC group have the figure on file, and a group prints from 6.

One filed metric per row, each a ratio of two figures from the same annual report; no composite and no grade. Percentile is the share of the group’s other companies with a lower figure. A group prints from 6 companies with the figure. The group is drawn from our stored table (the S&P 500 issuers and the companies we cover, each with its newest annual report read), not from every filer in the class. Industry pages show the same medians by group.

Funds holding EXEL // SEC Form NPORT-P, not a licence
NPORT period ended · quarterly, filed about 60 days after the period · SEC Form NPORT-P filings

7 of 39 funds we scan hold EXEL

Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.

FundWeightAs of
IJH iShares Core S&P Mid-Cap ETF0.38%2026-06-30
MDY SPDR S&P MidCap 400 ETF0.38%2026-06-30
IWD iShares Russell 1000 Value ETF0.03%2026-06-30
IWB iShares Russell 1000 ETF0.02%2026-06-30
ITOT iShares Core S&P Total US Stock Market ETF0.02%2026-06-30
VTI Vanguard Total Stock Market ETF0.02%2026-06-30
IWF iShares Russell 1000 Growth ETF0.01%2026-06-30

Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.

Where EXEL is incorporated // the company’s own filing
10-Q cover filed · checked · as of the latest periodic report cover · the company's own report cover, EDGAR's directory as a cross-check

Incorporated in Delaware, United States

Head office: Alameda, California, United States · the company’s charter and its head office are in different states.

Source: the cover page of EXELIXIS, INC.’s 10-Q filed 2026-10-29, on EDGAR. Filings checked 2026-11-22. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works

fair value // DCF · reverse DCF · Graham — no black boxestimate, not a target
inputs from the fiscal year ended · price close · annual filings, one daily close · SEC XBRL companyfacts and end-of-day bars (Databento)
FAIR-VALUE RANGE
$23.54 to $85.75
CURRENT PRICE
$64.63
-15%
TWO-STAGE DCF
$85.75
+33% vs price
8% growth for 10y, 2.5% terminal, 9% discount
GRAHAM NUMBERBenjamin Graham's ceiling for a cautious buyer: the highest share price his 1949 rule allows, at 15 times earnings and 1.5 times book value combined. A yardstick, not a forecast.
$23.54
-64% vs price
√(22.5 × EPS × book value/share)
4.3%
FCF growth the current price implies for 10y.
YOUR ASSUMPTIONS — TWEAK ANYTHING
ASSUMPTION RECEIPTS: YOUR STAGE-1 GROWTH OF 8.0% AGAINST EXEL’S FILED RECORD
Free cash flow per share, realized
3 FILED YEARS
fiscal 2022 to 2026
yours is 36.4 points lower
5 FILED YEARS
fiscal 2021 to 2026
yours is 32.0 points lower
10 FILED YEARS
Not computed. Free cash flow per share was negative in fiscal 2015, where this window starts, so a growth rate is not defined.
Diluted EPS, realized
3 FILED YEARS
fiscal 2022 to 2026
yours is 62.6 points lower
5 FILED YEARS
fiscal 2021 to 2026
yours is 43.4 points lower
10 FILED YEARS
Not computed. Diluted EPS was negative in fiscal 2015, where this window starts, so a growth rate is not defined.
The annual reports behind these rates
Free cash flow per shareThat yearYear before, same reportChangeReport
fiscal 20263.11 USD2.27 USD+37.0%10-K filed 2026-02-10
fiscal 20252.27 USD0.91 USD+148.9%10-K filed 2025-02-11
fiscal 20230.91 USD1.03 USD-11.7%10-K filed 2024-02-06
fiscal 20221.03 USD1.08 USD-4.0%10-K filed 2023-02-07
fiscal 20211.04 USD0.56 USD+85.9%10-K filed 2022-02-18
fiscal 20210.56 USD1.63 USD-65.6%10-K filed 2021-02-11
fiscal 20201.63 USD1.22 USD+33.5%10-K filed 2020-02-25
fiscal 20181.22 USD0.46 USD+164.0%10-K filed 2019-02-22
fiscal 20170.46 USD0.83 USD-44.4%10-K filed 2018-02-26
fiscal 20160.82 USD-0.68 USDnot a growth rate (a year at or below zero)10-K filed 2017-02-27

Concepts read: (us-gaap:NetCashProvidedByUsedInOperatingActivities - us-gaap:PaymentsToAcquirePropertyPlantAndEquipment) / us-gaap:NetIncomeLoss / us-gaap:EarningsPerShareBasicAndDiluted; (us-gaap:NetCashProvidedByUsedInOperatingActivities - us-gaap:PaymentsToAcquirePropertyPlantAndEquipment) / us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Diluted EPSThat yearYear before, same reportChangeReport
fiscal 20262.78 USD1.76 USD+58.0%10-K filed 2026-02-10
fiscal 20251.76 USD0.65 USD+170.8%10-K filed 2025-02-11
fiscal 20230.65 USD0.56 USD+16.1%10-K filed 2024-02-06
fiscal 20220.56 USD0.72 USD-22.2%10-K filed 2023-02-07
fiscal 20210.72 USD0.35 USD+105.7%10-K filed 2022-02-18
fiscal 20210.35 USD1.02 USD-65.7%10-K filed 2021-02-11
fiscal 20201.02 USD2.21 USD-53.8%10-K filed 2020-02-25
fiscal 20182.21 USD0.49 USD+351.0%10-K filed 2019-02-22
fiscal 20170.49 USD-0.28 USDnot a growth rate (a year at or below zero)10-K filed 2018-02-26
fiscal 2016-0.28 USD-0.77 USDnot a growth rate (a year at or below zero)10-K filed 2017-02-27

Concepts read: us-gaap:EarningsPerShareBasicAndDiluted; us-gaap:EarningsPerShareDiluted

Per filed share, as each report states it. Free cash flow per share is operating cash flow less capital expenditure, over the diluted weighted average share count (or net income over diluted EPS where the count is tagged per share class).

Each year’s change comes from one annual report, which states that year and the year before on the same share basis, and the rate compounds those changes; so a split or a restatement between reports cannot bend it. A rate needs a positive figure at both ends of its window. The DCF above grows total free cash flow and divides by today’s share count, so a per-share rate also carries the buybacks or new shares of those years. These are past figures, not a forecast.

Not shown yet: the P/E range EXEL has traded at, which would set the discount rate and terminal assumptions against its own history. It needs a long daily price history we are not yet licensed to display.

SENSITIVITY: DCF VALUE PER SHARE

Stage-1 growth down the side, discount rate across the top, with terminal growth at 2.5% and 10 years of stage 1. Every cell runs the same two-stage DCF as the card above, so moving a slider moves the grid.

Growth ↓ Discount →7%8%9%10%11%
4%92.3275.2063.3754.7048.09
6%108.5387.9273.7063.3155.40
8%127.52102.7985.7573.3263.88
10%149.72120.1299.7784.9573.70
12%175.62140.31116.0698.4385.07
Growth the close implies-0.4%2.1%4.3%6.3%8.2%

Outlined: your current pair. Shaded: at or above the last close, 64.63 USD. The heavy line runs between the cells on either side of it.

Plain English for every number above. One AI generation, or free if someone already asked about these numbers.
THE INPUTS — FROM EXEL’S FILINGS, FY ENDING 2026-01-02
Free cash flow $875.8MShares 0.24BDiluted EPS $2.78Book value/share $8.86

Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from EXEL’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.

revenue // quarterly$659M
quarters ended · through · 12 quarters, as filed · SEC XBRL companyfacts
2023-03-31: $409M2023-06-30: $470M2023-09-29: $472M2024-03-29: $425M2024-06-28: $637M2024-09-27: $540M2025-04-04: $555M2025-07-04: $568M2025-10-03: $598M2026-04-03: $611M2026-07-03: $629M2026-10-02: $659M
2023-03-312026-10-02
net income // quarterly$218M
quarters ended · through · 12 quarters, as filed · SEC XBRL companyfacts
2023-03-31: $40M2023-06-30: $81M2023-09-29: $1M2024-03-29: $37M2024-06-28: $226M2024-09-27: $118M2025-04-04: $160M2025-07-04: $185M2025-10-03: $194M2026-04-03: $210M2026-07-03: $212M2026-10-02: $218M
2023-03-312026-10-02
eps diluted // quarterly$0.85
quarters ended · through · 12 quarters, as filed · SEC XBRL companyfacts
2023-03-31: $0.122023-06-30: $0.252023-09-29: $0.002024-03-29: $0.122024-06-28: $0.772024-09-27: $0.402025-04-04: $0.552025-07-04: $0.652025-10-03: $0.692026-04-03: $0.792026-07-03: $0.822026-10-02: $0.85
2023-03-312026-10-02

↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated

As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as EXEL tagged it: revenue us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, net income us-gaap:NetIncomeLoss, EPS us-gaap:EarningsPerShareDiluted, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.

whales holding EXEL // latest 13FsWHO HOLDS EXEL →
13F quarter ended · quarterly, filed up to 45 days after the quarter · each fund's latest SEC Form 13F-HR
Renaissance Technologies$747.2M1.0% of portfolio
Also held by the funds that hold EXEL // counted from their 13Fs
oldest 13F quarter ended · newest · quarterly, filed up to 45 days after the quarter · each fund's latest SEC Form 13F-HR

1 of the 63 tracked funds hold EXEL among their 25 largest positions. A co-holding count needs at least 3 holding funds, because fewer is one or two portfolios read aloud, so no list is shown.

insider activity EXEL // Form 4, open-market0 buys · 4 sellsFULL TRACKER →
newest Form 4 filed · each Form 4 as filed, open-market trades over about six months · SEC Form 4 filings

Of 4 sales in the last ~6 months, 3 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 1 was filed without it.

Beckerle Mary CDirectorSELLplan$527K9,812 @ $53.663mo agoview →
WYSZOMIERSKI JACK LDirectorSELLplan$198K3,925 @ $50.556mo agoview →
Eckhardt Sue GailDirectorSELLplan$492K9,812 @ $50.146mo agoview →
Aftab DanaEVP, Research and DevelopmentSELL$2.2M43,451 @ $50.356mo agoview →
congress traded EXEL // STOCK ActFULL TRACKER →
feed generated · each disclosure as filed, up to 45 days after the trade · STOCK Act disclosures via the Congress Trading Monitor

No lawmaker has disclosed a trade in EXEL under the STOCK Act.

research brief // the filing-grounded overview + SWOTNEW

A plain-English read on EXEL plus an auto-SWOT, built from EXEL's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.

research committee // bull vs bear, from the filingsNEW

Four AI analysts, a bull, a bear, a risk manager, and a PM, debate EXEL using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.

ask EXEL // answered from its filing evidence

Ask about EXEL’s revenue, earnings, valuation, filings, insiders or Congress trades. Answers come only from the numbered evidence the research brief uses, each citing the items it rests on. A question about one figure is answered by code, free. One that puts figures together is 1 generation (Pro). A question about whether to buy, sell or hold, how much, or where the price goes gets a refusal.

analyze EXEL // every tool pre-filled
Stock Correlation Matrix →Position Size →Options Profit →Iron Condor & Credit Spread →Range Base Rate →DCF →Risk/Reward Ratio →Stock Profit →Average Cost →DRIP →Percentage Gain →Stock Break-Even →Covered Call & Cash-Secured Put →Stock Split →Capital Gains Tax →Graham Number →Move Claim Check →
more tools for EXEL // filings, valuation, technicals, pre-filledALL TOOLS →
explore EXEL across stocktoolsthe graph
related stocks COMPARE THESE →

Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.